Elucidating the Innate Immunological Effects of Mild Magnetic Hyperthermia on U87 Human Glioblastoma Cells: An In Vitro Study
Cancer immunotherapies have been approved as standard second-line or in some cases even as first-line treatment for a wide range of cancers. However, immunotherapy has not shown clinically relevant success in glioblastoma (GBM). This is principally due to the brain’s “immune-privileged” status and t...
Main Authors: | Stefano Persano, Francesco Vicini, Alessandro Poggi, Jordi Leonardo Castrillo Fernandez, Giusy Maria Rita Rizzo, Helena Gavilán, Niccolo Silvestri, Teresa Pellegrino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/10/1668 |
Similar Items
-
Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma
by: Yin Huaqi, et al.
Published: (2023-10-01) -
Graphene-Induced Hyperthermia (GIHT) Combined With Radiotherapy Fosters Immunogenic Cell Death
by: Malgorzata J. Podolska, et al.
Published: (2021-08-01) -
ADJUVANT CHEMORADIOTHERAPY WITH LOCAL HYPERTHERMIA IN COMBINED TREATMENT OF PRIMARY GLIOBLASTOMA: PRELIMINARY RESULTS
by: A. I. Ryabova, et al.
Published: (2017-03-01) -
A Novel Approach on Microwave Hyperthermia
by: Gulsah Altintas, et al.
Published: (2021-03-01) -
Malignant hyperthermia: current approaches to prevention and treatment
by: E. S. Kim, et al.
Published: (2017-09-01)